Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Godavari Drugs Ltd (NSE: GODAVARI), ISIN INE362C01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GODAVARI last traded at ₹124.80 (+2.34%), with a 52-week range of ₹69.70 to ₹144.35 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 40.23%, FIIs 0.00%, DIIs 2.79%, mutual funds 1.31%.
EquiSense Score (ECS): 48/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.